Join our community of traders FOR FREE!

  • Learn
  • Improve yourself
  • Get Rewards
Learn More

According to a person with knowledge of the matter, Actavis Plc, which is currently considered as the second largest generic-drug manufacturer by market value in the world, is close to acquiring Forest Laboratories Inc. in a deal estimated to 25 billion dollars.

The person familiar with the deal, who asked not to be named because the negotiations are not public, revealed that the purchase could be announced as early as today U.S. time. The market value of Forest Laboratories Inc. is estimated to 19.3 billion dollars.

According to data compiled by Bloomberg, Actavis Plc was the most active pharmaceutical companies buyer in the past three years. Its acquisitions amounted to 14.4 billion dollars.

Ori Hershkovitz, who is a partner at Sphera Funds Management Ltd., said that the company relies mainly on mergers and purchases in order to maintain its earning growth, especially considering the fact that new drugs research and development is quite an expensive process.

“They have promised the market that they would do a large amount of deals to keep the accretion alive,” Hershkovitz said for Bloomberg. “If you can’t do a large amount of R&D, there’s only one way to grow and that’s through M&A.”

According to data compiled by Bloomberg, the purchase of Forest Laboratories Inc. would prove out to be beneficial for the investor Carl Icahn, who became a board member of Forest in 2012 and currently is the second-largest shareholder of the company.

A person with knowledge of the negotiations shared that the current Chief Executive Officer Brent Saunders is expected to head the combined company if the deal is successfully finalized. Saunders, who is also a former Chief Executive Officer of Bausch & Lomb Inc., took the CEO position of Forest Laboratories in September 2013. Last month the company announced that an agreement with Aptalis Pharma Inc. was reached. The deal was estimated to 2.9 billion dollars and was important for Forest in order to help it add treatments for gastrointestinal ailments and cystic fibrosis in its portfolio.

Actavis Plc rose by 0.13% on Friday to settle the session at $191.88, marking a one-year change of +121.85%. According to CNN Money, the 17 analysts offering 12-month price forecasts for Actavis PLC have a median target of $210.00, with a high estimate of $230.00 and a low estimate of $179.00. The median estimate represents a +9.44% increase from the last price close.

TradingPedia.com is a financial media specialized in providing daily news and education covering Forex, equities and commodities. Our academies for traders cover Forex, Price Action and Social Trading.

Related News

  • Zeo Energy Corp appoints Chief Financial OfficerZeo Energy Corp appoints Chief Financial Officer Zeo Energy Corp (Nasdaq: ZEO), a provider of residential solar and energy efficiency solutions, said this week it had appointed Cannon Holbrook as its next Chief Financial Officer.Holbrook, who joined Zeo Energy in March, brings more […]
  • Commodity Market: US Crude Oil retreats as virus-related demand recovery concerns weighCommodity Market: US Crude Oil retreats as virus-related demand recovery concerns weigh Futures on US West Texas Intermediate Crude Oil retreated over 1% on Tuesday, while erasing gains achieved a day earlier, on mounting fears that continuing rise in new COVID-19 cases across the United States, the largest oil consumer […]
  • Forex Market: USD/JPY daily trading forecastForex Market: USD/JPY daily trading forecast Yesterday’s trade saw USD/JPY within the range of 119.77-121.39. The pair closed at 121.03, soaring 0.93% on a daily basis, or the most considerable daily gain since July 10th, when it appreciated 1.16%. The daily high has also been the […]
  • Forex Market: GBP/CHF daily forecastForex Market: GBP/CHF daily forecast During yesterday’s trading session GBP/CHF traded within the range of 1.5316-1.5356 and closed at 1.5332.At 6:21 GMT today GBP/CHF was gaining 0.08% for the day to trade at 1.5346. The pair touched a daily high at 1.5347 at 6:10 […]
  • Google share price up, to team up with BlackBerry on Android for WorkGoogle share price up, to team up with BlackBerry on Android for Work Google Inc launched its new work-related initiative on Wednesday and announced it had reached an agreement with Blackberry to improve security on Android devices.Android for Work was officially released yesterday following its introduction […]
  • Grain futures mixed, soybeans gain on frost concernGrain futures mixed, soybeans gain on frost concern Grain futures were mixed on Friday with corn declining, while wheat gained and soybeans advanced on concern over frost damage and increased U.S. exports.On the Chicago Board of Trade, soybeans for September delivery traded at $12.3638 a […]